Sleeping Beauty Insertional Mutagenesis Reveals Important Genetic Drivers of Central Nervous System Embryonal Tumors

Area of Science:

• Oncology
• Genetics
• Molecular Biology

Background:

• Medulloblastoma and CNS-PNET are aggressive pediatric brain tumors with poor prognoses.
• Current therapies for these tumors are limited, necessitating the discovery of novel therapeutic targets.

Purpose of the Study:

• To identify novel genetic drivers of medulloblastoma and CNS-PNET using Sleeping Beauty transposon mutagenesis.
• To develop genetically engineered mouse models for CNS-PNET and specific medulloblastoma subgroups.

Main Methods:

• Utilized Sleeping Beauty (SB) transposon mutagenesis to induce tumors in mice.
• Performed cross-species gene expression analyses to classify tumor subgroups.
• Conducted in vitro and in vivo genetic manipulation experiments.

Main Results:

• Identified novel proto-oncogenes, including Arhgap36, Megf10, and Foxr2, as genetic drivers.
• Developed the first genetically induced mouse model for CNS-PNET and rare models for group 3 and 4 medulloblastoma.
• Demonstrated that FOXR2 interacts with N-MYC, stabilizes C-MYC, and activates FAK/SRC signaling.

Conclusions:

• The study identified promising therapeutic targets for medulloblastoma and CNS-PNET.
• The developed mouse models offer valuable platforms for studying these aggressive brain tumors.
• Targeting identified genetic drivers like FOXR2 presents a potential therapeutic strategy.